Major Price Cuts Announced for Medications in Morocco
In a notable development for healthcare in Morocco, prices for approximately 300 medications are set to decrease significantly, with reductions expected to range between 10% and 70%. This initiative marks a crucial step in implementing the new reform aimed at regulating drug pricing in the country. A source from the Ministry of Health and Social Protection revealed that an initial list of nearly 300 medications has been approved, which will see varying price cuts for consumers in the coming months.
This decision follows closely on the heels of the publication of decree number 2.25.631, which was issued on July 23, 2026. This decree introduced several modifications to the existing pricing system that had been in place since 2013. One of the most significant changes is the adjustment of medication prices to occur more regularly, with reviews now taking place every three years instead of the previous five-year interval. Additionally, new pricing comparison rules with reference countries have been established, allowing for further price reductions on a number of medications.
It is important to note that this initial list is just the beginning; the new framework mandates a review of the prices of medications already on the market within twelve months of implementation. This suggests that additional price adjustments are likely to follow in the near future. The overarching goal of these reforms is to lower the cost of medications, thereby improving access to treatment and reducing the financial burden on patients. This move is expected to alleviate the expenses that individuals incur and lessen the financial strain on the compulsory health insurance system.
As reported by hespress.com.
